BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16644119)

  • 1. Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells.
    Marco S; Skaper SD
    Neurosci Lett; 2006 Jul; 401(3):219-24. PubMed ID: 16644119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease.
    Schultheiss C; Blechert B; Gaertner FC; Drecoll E; Mueller J; Weber GF; Drzezga A; Essler M
    Angiogenesis; 2006; 9(2):59-65. PubMed ID: 16821113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of integrins in angiogenesis.
    Brooks PC
    Eur J Cancer; 1996 Dec; 32A(14):2423-9. PubMed ID: 9059330
    [No Abstract]   [Full Text] [Related]  

  • 4. Requirement of vascular integrin alpha v beta 3 for angiogenesis.
    Brooks PC; Clark RA; Cheresh DA
    Science; 1994 Apr; 264(5158):569-71. PubMed ID: 7512751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders.
    Sweeney MD; Sagare AP; Zlokovic BV
    Nat Rev Neurol; 2018 Mar; 14(3):133-150. PubMed ID: 29377008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
    Carrano A; Hoozemans JJ; van der Vies SM; Rozemuller AJ; van Horssen J; de Vries HE
    Antioxid Redox Signal; 2011 Sep; 15(5):1167-78. PubMed ID: 21294650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression.
    Yamazaki Y; Shinohara M; Shinohara M; Yamazaki A; Murray ME; Liesinger AM; Heckman MG; Lesser ER; Parisi JE; Petersen RC; Dickson DW; Kanekiyo T; Bu G
    Brain; 2019 Apr; 142(4):1077-1092. PubMed ID: 30770921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: A matter of blood-brain barrier dysfunction?
    Montagne A; Zhao Z; Zlokovic BV
    J Exp Med; 2017 Nov; 214(11):3151-3169. PubMed ID: 29061693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The blood-brain barrier in Alzheimer's disease.
    Zenaro E; Piacentino G; Constantin G
    Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Blood-Brain Barrier in Alzheimer's Disease.
    Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
    J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
    Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
    Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Barrier: From Physiology to Disease and Back.
    Sweeney MD; Zhao Z; Montagne A; Nelson AR; Zlokovic BV
    Physiol Rev; 2019 Jan; 99(1):21-78. PubMed ID: 30280653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
    Yamazaki Y; Kanekiyo T
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy.
    Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ
    Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blood-brain barrier in health and chronic neurodegenerative disorders.
    Zlokovic BV
    Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.
    Nation DA; Sweeney MD; Montagne A; Sagare AP; D'Orazio LM; Pachicano M; Sepehrband F; Nelson AR; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Chui HC; Law M; Toga AW; Zlokovic BV
    Nat Med; 2019 Feb; 25(2):270-276. PubMed ID: 30643288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.
    Magaki S; Tang Z; Tung S; Williams CK; Lo D; Yong WH; Khanlou N; Vinters HV
    Neurobiol Aging; 2018 Oct; 70():70-77. PubMed ID: 30007166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease.
    Halliday MR; Rege SV; Ma Q; Zhao Z; Miller CA; Winkler EA; Zlokovic BV
    J Cereb Blood Flow Metab; 2016 Jan; 36(1):216-27. PubMed ID: 25757756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier breakdown in the aging human hippocampus.
    Montagne A; Barnes SR; Sweeney MD; Halliday MR; Sagare AP; Zhao Z; Toga AW; Jacobs RE; Liu CY; Amezcua L; Harrington MG; Chui HC; Law M; Zlokovic BV
    Neuron; 2015 Jan; 85(2):296-302. PubMed ID: 25611508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.
    Zipser BD; Johanson CE; Gonzalez L; Berzin TM; Tavares R; Hulette CM; Vitek MP; Hovanesian V; Stopa EG
    Neurobiol Aging; 2007 Jul; 28(7):977-86. PubMed ID: 16782234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.